Infoblox plummets after revenue warning

Infoblox Inc. warned investors Monday that revenue would come in well below expectations, and shares in the networking-software company dove more than 12% in late trading. Infoblox said it expects revenue for the first quarter to be $81 million to $82 million, after previously providing a forecast of $91 million to $93 million, and expects adjusted profit of 5 cents to 6 cents a share. Analysts polled by FactSet expected the company to report adjusted earnings of 6 cents a share on sales of $92 million. Infoblox also dropped its full-year revenue guidance to $354 million to $358 million, compared with a previous estimate of $370 to $380 million. Chief Executive Jesper Andersen, a former Cisco Systems Inc. executive who was brought in to stem a decline at Infoblox, said weakness in enterprise IT spending, especially in North America, was to blame for the shortfall. “We are actively addressing these near-term challenges by continuing to focus on improvements in sales execution and operational efficiency,” the CEO said in Monday’s announcement. Infoblox shares fell lower than $14 in late trading after closing with a 0.5% decline at $15.52. The company expects to fully report earnings and hold a conference call on May 25.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

NewLink shares plummet 40% after disappointing cancer drug study

NewLink Genetics Corp. shares plummeted in the extended session Monday after the biotech company said its study for a pancreatic cancer drug did not reach its primary goal. NewLink shares dropped 40% to $9.97 on heavy volume after hours following a brief trading halt. The company said a late-stage clinical trial for its algenpantucel-L treatment did not statistically improve survival rates in patients with resected pancreatic cancer. “In light of these negative results, our scientific and clinical teams will focus on other promising opportunities in our pipeline,” said Charles Link, NewLink chairman and chief executive, in a statement.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

NewLink shares plummet 40% after disappointing cancer drug study

NewLink Genetics Corp. shares plummeted in the extended session Monday after the biotech company said its study for a pancreatic cancer drug did not reach its primary goal. NewLink shares dropped 40% to $9.97 on heavy volume after hours following a brief trading halt. The company said a late-stage clinical trial for its algenpantucel-L treatment did not statistically improve survival rates in patients with resected pancreatic cancer. “In light of these negative results, our scientific and clinical teams will focus on other promising opportunities in our pipeline,” said Charles Link, NewLink chairman and chief executive, in a statement.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

NewLink shares plummet 40% after disappointing cancer drug study

NewLink Genetics Corp. shares plummeted in the extended session Monday after the biotech company said its study for a pancreatic cancer drug did not reach its primary goal. NewLink shares dropped 40% to $9.97 on heavy volume after hours following a brief trading halt. The company said a late-stage clinical trial for its algenpantucel-L treatment did not statistically improve survival rates in patients with resected pancreatic cancer. “In light of these negative results, our scientific and clinical teams will focus on other promising opportunities in our pipeline,” said Charles Link, NewLink chairman and chief executive, in a statement.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

SolarCity shares drop on wider-than-expected loss, outlook

SolarCity Corp. shares dropped in the extended session Monday after the solar energy company posted a wider-than-expected loss for the first quarter, and issued a worse-than-expected outlook. SolarCity shares fell 15% to $19.07 after hours. The company reported an adjusted first-quarter loss of $2.56 on revenue of $122.6 million. Analysts surveyed by FactSet had forecast a loss of $2.31 a share on revenue of $110 million. For the second quarter, SolarCity sees an adjusted loss of $2.70 to $2.80 a share. Analysts had forecast a loss of $2.13 a share. SolarCity said it installed 214 megawatts of panels in the first quarter, exceeding its guidance of 180 MW.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gap plunges after warning about sales decline, potential streamlining

Gap Inc. shares fell more than 9% Monday afternoon after the clothing retailer warned of a sales decline in the first quarter and said it is looking to streamline its operations. Specifically, the retailer said it is examining Banana Republic and Old Navy stores globally, but primarily outside North America, for potential changes. The clothier said that April sales declined to $1.12 billion from $1.21 billion year-over-year, and first-quarter sales fell to $3.44 billion from $3.66 billion. Profit in the first quarter is expected to be 31 to 32 cents per share. Analysts polled by FactSet expected Gap to report earnings of 44 cents a share on sales of $3.54 billion. Gap last year announced a streamlining of its namesake retail chain, with plans to close more than a quarter of those stores, and appears ready to make a similar move with its other clothing store chains. “Our industry is evolving and we must transform at a faster pace, while focusing our energy on what matters most to our customers,” Chief Executive Art Peck said in Monday’s announcement. Shares fell lower than $20 in late trading after closing with a 0.7% gain at $21.81. Gap plans to fully report first-quarter earnings on May 19.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Oil futures end lower as wildfire threats downplayed

Oil futures ended lower Monday, with analysts tying weakness to uncertainty over Saudi oil policy after the country replaced its oil minister and decreased worries about the impact of wildfires on Canadian oil output. Crude oil for June delivery on the New York Mercantile Exchange fell $1.22, or 2.7%, to end at $43.44 a barrel.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gold prices slide 2.1% as dollar strengthens

Gold prices slumped Monday, following a run-up on Friday, as the U.S. dollar gained strength. Gold for June delivery fell $27.40, or 2.1%, to settle at $1,266.60 an ounce. On Friday, gold rose 1.7% to finish at $1,294 an ounce. Silver for July delivery shed 43.8 cents, or 2.5%, to settle at $17.09 an ounce. On Monday, the U.S. dollar was trading 0.3% higher against a basket of major currencies.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gold prices slide 2.1% as dollar strengthens

Gold prices slumped Monday, following a run-up on Friday, as the U.S. dollar gained strength. Gold for June delivery fell $27.40, or 2.1%, to settle at $1,266.60 an ounce. On Friday, gold rose 1.7% to finish at $1,294 an ounce. Silver for July delivery shed 43.8 cents, or 2.5%, to settle at $17.09 an ounce. On Monday, the U.S. dollar was trading 0.3% higher against a basket of major currencies.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Shares of LendingClub are having their worst day on record after CEO’s ouster

It’s an ugly day for LendingClub Corp. On Monday, shares of the peer-to-peer lender were on track to post their worst one-day decline since it became a publicly traded company over a year ago. The lender’s stock was in free fall, shedding a quarter of its value. The share plunge comes after LendingClub’s CEO Renaud Laplanche resigned as chief executive and chairman after an internal review found sales of $22 million in near-prime loans to a single investor, against that investor’s explicit instructions. The 25% decline in its stock represents the most severe single-day drop since LendingClub went public Dec. 10, 2014 on the New York Stock Exchange. LendingClub is losing some $700 million in market value, representing its worst one-day decline in market capitalization since Feb. 25, 2015, according to Dow Jones data. Its market-cap valuation as of Monday midday was about $2 billion. LendingClub’s Monday announcement serves to heighten anxiety around companies who help trade consumer loans.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News